The Emerging Role of Artificial Intelligence in Organ-on-a-Chip (OOAC) Biomedical Devices

Abstract

Organ-on-a-chip technology, often referred to as OOAC, represents a revolutionary paradigm in biomedical engineering and research. It is a sophisticated microfluidic system that replicates the structure, function, and microenvironment of human organs on a miniature scale. The aim is to create a platform for studying organ-level physiology and pathology outside the human body, providing a more accurate and ethical alternative to traditional methods that often rely on animal testing. Furthermore, the ongoing progress in artificial intelligence (AI) brings additional enhancements to the design and data processing capabilities of OOACs. In this chapter, we explore the opportunities and obstacles entailed in the integration of OOACs and AI. In summary, the evolution of OOAC technology and its eventual synergy with AI have the potential to disrupt the current landscape of drug evaluation, presenting a promising path forward.